Multiple Choice
A 62-year-old woman is evaluated for refractory nausea and vomiting. She was recently diagnosed with ovarian cancer and underwent total hysterectomy with bilateral salpingo-oophorectomy and pelvic lymph node dissection. The patient was started on highly emetogenic adjuvant chemotherapy. Despite taking ondansetron around the clock, she continues to have nausea and vomiting. She has no abdominal pain or constipation. Vital signs are normal. Examination shows a well-healed abdominal scar. There is no tenderness or abnormal masses. Bowel sounds are normal. Additional therapy blocking which of the following receptors would most likely be helpful in this patient?
A) Endogenous opioid
B) Motilin
C) Neurokinin 1
D) Neuropeptide Y
E) Nicotinic acetylcholine
Correct Answer:

Verified
Correct Answer:
Verified
Q194: A 25-year-old graduate student comes to the
Q195: A 29-year-old woman comes to the office
Q196: A 44-year-old man comes to the office
Q197: A 21-year-old woman comes to the office
Q198: Researchers develop a novel glycopeptide antibiotic similar
Q200: A 52-year-old, post-menopausal woman comes to the
Q201: A 23-year-old woman comes to the emergency
Q202: A 56-year-old man with type 2 diabetes
Q203: A 44-year-old woman with a history of
Q204: A 23-year-old woman comes to the physician